Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Oct 09, 2024

SELL
$0.64 - $1.03 $64,000 - $103,000
-100,000 Reduced 21.16%
372,500 $302 Million
Q2 2023

Aug 11, 2023

SELL
$0.64 - $1.03 $64,000 - $103,000
-100,000 Reduced 21.16%
372,500 $301,000
Q1 2023

Oct 09, 2024

BUY
$0.46 - $0.77 $217,350 - $363,825
472,500 New
472,500 $331 Million
Q1 2023

May 15, 2023

BUY
$0.46 - $0.77 $25,530 - $42,735
55,500 Added 13.31%
472,500 $330,000
Q4 2022

Oct 09, 2024

SELL
$0.51 - $17.1 $52,785 - $1.77 Million
-103,500 Reduced 19.15%
437,000 $309 Million
Q4 2022

Feb 14, 2023

SELL
$0.51 - $17.1 $42,585 - $1.43 Million
-83,500 Reduced 16.68%
417,000 $294,000
Q3 2022

Oct 09, 2024

BUY
$1.01 - $17.0 $545,905 - $9.19 Million
540,500 New
540,500 $822 Million
Q3 2022

Nov 17, 2022

SELL
$1.01 - $17.0 $83,830 - $1.41 Million
-83,000 Reduced 14.22%
500,500 $761,000
Q2 2022

Oct 09, 2024

BUY
$0.54 - $1.41 $336,690 - $879,135
623,500 New
623,500 $619 Million
Q2 2022

Aug 09, 2022

BUY
$0.54 - $1.41 $9,774 - $25,521
18,100 Added 3.2%
583,500 $579,000
Q1 2022

Oct 08, 2024

BUY
$1.4 - $5.15 $272,300 - $1 Million
194,500 Added 42.2%
655,400 $944 Million
Q1 2022

May 10, 2022

BUY
$1.4 - $5.15 $230,299 - $847,175
164,500 Added 41.03%
565,400 $814,000
Q4 2021

Oct 08, 2024

BUY
$4.27 - $6.97 $1.97 Million - $3.21 Million
460,900 New
460,900 $2.41 Billion
Q4 2021

Oct 01, 2024

BUY
$4.27 - $6.97 $1.97 Million - $3.21 Million
460,900 New
460,900 $2.09 Billion
Q4 2021

May 10, 2022

BUY
$4.27 - $6.97 $1.71 Million - $2.79 Million
400,900 New
400,900 $2.09 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Cladis Investment Advisory, LLC Portfolio

Follow Cladis Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.